Arteriosclerosis or Vasculitis? Color Duplex Sonography in Giant Cell Arteritis
To the Editor:
We followed with great interest the report by Czihal, et al 1 presenting new possibilities of objective, noninvasive diagnostic procedures that remain insufficient in giant cell arteritis (GCA). We would like to share our clinical experiences with arteritic changes in patients with GCA.
Sonographic presentations of vasculitis may be mistaken for arteriosclerosis, especially in elderly patients who typically have GCA. That was the case in a patient with mild systemic manifestations and insidious disease onset. A 64-year-old woman presented with carotidynia -a rare manifestation of GCA. Color duplex sonography (CDS) revealed hypoechoic, homogenous, circumferential but not symmetrical bilateral wall thickening involving carotid and internal carotid arteries up to 15 mm from the carotid bifurcation ( Figure 1 ). The diagnosis of GCA was confirmed by a superficial temporal artery biopsy. An initial diagnosis of arteriosclerosis with long, uncalcified plaques in a patient suspected to have GCA requires reexamination. In the absence of clinical context the differential diagnosis of vascular changes may still be difficult.
The problem of differentiating arteriosclerosis from vasculitis using CDS examination is their possible close relationship. Vasculitis and its treatment with glucocorticosteroids may promote accelerated arteriosclerosis 2,3 . Moreover, calcifications in temporal artery biopsies belong to the histological picture of GCA. Some studies speculate that arterial calcifications in elderly patients may promote giant-cell formation and vasculitis 4 . Czihal, et al 1 describe "spot calcifications" or "beaded tube" appearance in lower extremity arteries of 65.5% patients classified as having vasculitis. It remains to be determined whether this represents a subtype of arteriosclerotic lesions, and if so is it primary or secondary to vasculitis? Whether this represents a specific sign of GCA also remains an important question for future studies. We may confirm this finding in some of our patients with GCA. For example, an 80-year-old woman was admitted to our department of rheumatology with pyrexia of unknown origin and cranial manifestations of GCA. She developed symptoms of intermittent claudication; however, she did not specifically describe them. They were mistaken with her chief complaints of general malaise and weakness and were attributed to polymyalgia rheumatica. Her CDS examination revealed an unusual appearance ( Figure 2 ) similar to that reported by Czihal, et al. Afterwards, she was tested for pain-free walking distance; it appeared to be about 200 m, but it doubled shortly after induction of glucocorticosteroid therapy. We also agree with Czihal, et al that the experience with patients with GCA is strongly influenced by the profile of the department. Most of our patients show cranial manifestations of the disease. It may therefore be difficult to estimate the prevalence of femoropopliteal involvement in GCA.
Whether wall thickening is related to vasculitis or arteriosclerosis might be supported by the improvement or lack of improvement after proper treatment in patients with GCA. This was demonstrated in studies on contrasted computerized tomography of the aorta 5 . The improvement of the aortic wall thickening was usually partial 6 . However, no improvement after the treatment was found by Czihal, et al or in other studies based on CDS 7 . Thus, more data from prospective studies are needed.
We agree with Czihal, et 
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